BusinessCompany NewsAstraZeneca takes $104m IFRS hit

AstraZeneca takes $104m IFRS hit

Drugs giant AstraZeneca has restated its 2003 results under international financial reporting standards, resulting in a $104m (£56m) reduction in operating profit.

Link: Corporate governance – Are analysts up to the IFRS job?

The figures, released this morning, are ‘designed to enable shareholders and the financial community to make comparisons when the new IAS/IFRS guidance is fully introduced from 1 January 2005,’ according to Jonathan Symonds, chief financial officer of AstraZeneca.

Symonds is also chairman of the FTSE100 group of finance directors, and the restatement, believed to be the first of its kind, is widely seen as an exercise of leading by example.

The $104m hit was described by Symonds as ‘modest’ in the group’s overall operating profit of over $4.1bn.

Related Articles

M&S business rate liabilities based on £570m rateable value

Company News M&S business rate liabilities based on £570m rateable value

4m Emma Smith, Managing Editor
BDO replaces Deloitte as Mitie auditor

Audit BDO replaces Deloitte as Mitie auditor

8m Emma Smith, Managing Editor
CVR Global appoints partner in London office

Company News CVR Global appoints partner in London office

1y Alia Shoaib, Reporter
FTSE100 failing to provide adequate ethics information

Company News FTSE100 failing to provide adequate ethics information

1y Alia Shoaib, Reporter
Moore Stephens recruits new private client partner

Accounting Firms Moore Stephens recruits new private client partner

1y Emma Smith, Managing Editor
Magma Group announces merger, partner promotions

Accounting Firms Magma Group announces merger, partner promotions

1y Emma Smith, Managing Editor
BDO on ‘recruitment spree’ with multiple partner appointments

Accounting Firms BDO on ‘recruitment spree’ with multiple partner appointments

1y Emma Smith, Managing Editor
Brand strength leads to fee income growth for RSM

Accounting Firms Brand strength leads to fee income growth for RSM

1y Emma Smith, Managing Editor